ArticleMolecular therapy. Oncology2024

Solid cancer-directed CAR T cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1.

Yan Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.